Showing results (391-400 of 463) with videos related to
Sort By:
Pageof 47
Pediatric Blood & Cancer|July 23, 2026
Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical StudiesPrzemysław Holko, Holger N Lode, Alberto Garaventa, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacementR Jeffrey Neitz, Andrei W Konradi, Hing L Sham, et al.Trials|September 18, 2012
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trialMatthew R Sydes, Mahesh K B Parmar, Malcolm D Mason, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 10, 2025
What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease?Kathryn Willis, Royce Shakespeare, Lakshmi Chandrasekaran, et al.Journal of Clinical Gastroenterology|June 29, 2026
International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal BleedingMohamed Hussein, Apostolis Papaefthymiou, Sachin Wani, et al.Cancer Letters|February 1, 2025
ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastomaFederica Lorenzi, Sina Jostes, Qiong Gao, et al.Frontiers in Oncology|February 9, 2026
Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisonsHolger N Lode, Przemysław Holko, Aleksandra Wieczorek, et al.Science Translational Medicine|May 29, 2024
Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcomaDaniel Fowler, Marta Barisa, Alba Southern, et al.The British Journal of Ophthalmology|October 24, 2023
Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effectAbraham Olvera-Barrios, Alicja R Rudnicka, John Anderson, et al.Neuro-Oncology|April 30, 2020
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerKenneth D Westover, J Travis Mendel, Tu Dan, et al.Pageof 47